MARCELA PEREZ: Open Payments
NPI 1386316404 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 12 payments from 9 companies in 2025. Trend: 2023 $444 · 2024 $482 · 2025 $459
Food & beverage: $359Education: $100
| Company | Payments | Amount |
|---|---|---|
| Verastem, Inc. | 1 | $124 |
| SEAGEN INC. | 1 | $100 |
| Merck Sharp & Dohme LLC | 3 | $60 |
| Janssen Biotech, Inc. | 2 | $58 |
| Eisai Inc. | 1 | $29 |
| Ipsen Biopharmaceuticals, Inc | 1 | $28 |
| Syndax Pharmaceuticals, Inc. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $18 |
Products named: AVMAPKI FAKZYNJA CO-PACK, KEYTRUDA, DARZALEX, Lenvima, Onivyde, LYNOZYFIC, PADCEV.
Industry payments across TX — which companies pay providers there.
